Prognostic value of platelet-to-lymphocyte ratio in patients with unresectable hepatocellular carcinoma undergoing transarterial chemoembolization and tyrosine kinase inhibitors plus immune checkpoints inhibitors

Prognostic value of platelet-to-lymphocyte ratio in patients with unresectable hepatocellular carcinoma undergoing transarterial chemoembolization and tyrosine kinase inhibitors plus immune checkpoints inhibitors

PurposeTo investigate the prognostic value of platelet-to-lymphocyte ratio (PLR) in patients with unresectable hepatocellular carcinoma (uHCC) treated with transarterial chemoembolization (TACE) and tailored tyrosine kinase inhibitors (TKIs) plus immune checkpoints inhibitors (ICIs).Materials and me...

Full description

Bibliographic Details
Main Authors: Yiwan Guo, Wenlong Wu, Bo Sun, Tingting Guo, Keke Si, Chuansheng Zheng, Xin Li
Format: Article
Language:English
Published: Frontiers Media S.A. 2024-01-01
Series:Frontiers in Oncology
Subjects:
platelet-to-lymphocyte ratio
hepatocellular carcinoma
transarterial chemoembolization
tailored tyrosine kinase inhibitors
immune checkpoint inhibitors
Online Access:https://www.frontiersin.org/articles/10.3389/fonc.2024.1293680/full

Internet

https://www.frontiersin.org/articles/10.3389/fonc.2024.1293680/full

Similar Items